That downhill slide is reflected in responses from disgruntled BlinkRx buyers in all kinds of other areas. On copyright, wherever the critiques are fairly evenly break up at 45% 5-stars and 39% one-star (using an warn from copyright stating the pharmacy could be stacking the deck with "unsupported invitation approaches"), you will see responses dec… Read More